Draghia-Akli Ruxandra bought NVAX
March 3, 2025 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 80,000 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
80,000
Price
$0.00
Total value
N/A
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
Security2025 Restricted Stock Units RSU
Transaction codeA: Grant or award
Transaction dateMarch 3, 2025
Filing dateMarch 5, 2025
Shares owned after80,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.